Furuse Yuki
Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Front Med (Lausanne). 2024 Jan 10;10:1288014. doi: 10.3389/fmed.2023.1288014. eCollection 2023.
During the COVID-19 pandemic, a large number of research papers were published, and some of them were retracted. The present study aims to reveal the characteristics of retracted papers before and during the pandemic.
The study investigated 24,542,394 publications from 1999 to 2022 and analyzed the profiles of retracted papers from the perspectives of year, disease category, country, and journal.
Retraction rates were generally increasing at least until 2019, and were the highest for "Neoplasms." The number of publications for "Infections" and "Respiratory Tract Diseases" dramatically rose during the COVID-19 pandemic; however, the retraction rates in the two categories or of COVID-19-related papers were not especially high compared to other diseases. The association with retraction was strongest for China in most disease categories, whereas for COVID-19 papers, other countries showed higher retraction rates than China. In recent years, retracted papers have become less likely to be published in high-impact journals.
The COVID-19 pandemic does not seem to affect the retractions of research papers much. We should keep monitoring retractions and analyze the effects of pandemics for better science.
在新冠疫情期间,发表了大量研究论文,其中一些被撤回。本研究旨在揭示疫情之前和期间被撤回论文的特征。
该研究调查了1999年至2022年的24,542,394篇出版物,并从年份、疾病类别、国家和期刊的角度分析了被撤回论文的概况。
至少到2019年,撤稿率总体呈上升趋势,其中“肿瘤”类别的撤稿率最高。在新冠疫情期间,“感染性疾病”和“呼吸道疾病”的出版物数量大幅增加;然而,与其他疾病相比,这两类或与新冠相关论文的撤稿率并非特别高。在大多数疾病类别中,中国与撤稿的关联最为密切,而对于新冠相关论文,其他国家的撤稿率高于中国。近年来,被撤回的论文在高影响力期刊上发表的可能性降低。
新冠疫情似乎对研究论文的撤稿影响不大。我们应持续监测撤稿情况,并分析疫情的影响,以推动更优质的科研。